Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2008-01-01
2008-01-01
Bragdon, Kathleen Kerr (Department: 1656)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S333000, C530S384000, C530S412000, C424S094640, C424S529000, C435S212000, C435S226000
Reexamination Certificate
active
07314917
ABSTRACT:
The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.
REFERENCES:
patent: 4904584 (1990-02-01), Shaw
patent: 5009889 (1991-04-01), Taylor, Jr. et al.
patent: 5225537 (1993-07-01), Foster
patent: 5258288 (1993-11-01), Wydro et al.
patent: 5288629 (1994-02-01), Berkner
patent: 5460950 (1995-10-01), Barr et al.
patent: 5504064 (1996-04-01), Morrissey et al.
patent: 5580560 (1996-12-01), Nicolaisen et al.
patent: 5648254 (1997-07-01), Mulvihill et al.
patent: 5788965 (1998-08-01), Berkner et al.
patent: 5817788 (1998-10-01), Berkner et al.
patent: 5824639 (1998-10-01), Berkner et al.
patent: 5833982 (1998-11-01), Berkner et al.
patent: 5837843 (1998-11-01), Smirnov et al.
patent: 5847085 (1998-12-01), Esmon et al.
patent: 5861374 (1999-01-01), Berkner et al.
patent: 5965425 (1999-10-01), Barr et al.
patent: 5986079 (1999-11-01), Barr et al.
patent: 6017882 (2000-01-01), Nelsestuen
patent: 6071514 (2000-06-01), Grinnell et al.
patent: 6100061 (2000-08-01), Reiter et al.
patent: 6423826 (2002-07-01), Nelsestuen et al.
patent: 6475725 (2002-11-01), Reiter et al.
patent: 6693075 (2004-02-01), Nelsestuen
patent: 6747003 (2004-06-01), Nelsestuen
patent: 6762286 (2004-07-01), Nelsestuen
patent: 2003/0100506 (2003-05-01), Nelsestuen
patent: 2003/0211094 (2003-11-01), Nelsestuen
patent: 2003/0211460 (2003-11-01), Nelsestuen
patent: 0 296 413 (1988-12-01), None
patent: 0 354 504 (1990-02-01), None
patent: 0 512 011 (1992-11-01), None
patent: 64-085096 (1989-03-01), None
patent: WO 88/10295 (1988-12-01), None
patent: WO 96/00577 (1996-01-01), None
patent: WO 99/20767 (1999-04-01), None
patent: WO 00/54787 (2000-09-01), None
patent: 9809597 (1999-04-01), None
Arnljots, et al.,J. Vasc. Surg., 1997, 25:341-346.
Bauer,Haemostasis, 1996, 26:155-158, suppl. 1.
Broze, et al.,J. Clin. Invest., 1985, 76:937-946.
Choudhri, et al.,J. Exp. Med., 1999, 190:91-99.
Christiansen, et al.,Biochemistry, 1995, 34:10376-10382.
Dackiw, et al.,Arch. Surg., 1996, 131:1273-1278.
Dahlback,Blood, 1995, 85:607-614.
Esmon, et al.,J. Biol. Chem., 1982, 257:859-864.
Evans, Jr. and Nelsestuen,Biochemistry, 1996, 35:8210-8215.
Evans and Nelsestuen,Protein Sci., 1996, 5:supp. 1, 163 Abs.
Felgner, et al.,Proc. Natl. Acad. Sci. USA, 1987, 84:7413-7417.
Fiore, et al.,J. Biol. Chem., 1994, 269:143-149.
Freedman, et al.,J. Biol. Chem, 1996, 271(27):16227-16236.
Furie and Furie,Cell, 1988, 53:505-518.
Han, et al.,Proc. Natl. Acad. Sci. USA, 1998, 95:9250-9255.
He, et al.,Eur. J. Biochem., 1995, 227:433-440.
Hedner, et al.,Transfus. Medi. Rev., 1993, 7:78-83.
Hope, et al.,Biochem. Biophys. Acta., 1985, 812:55-65.
Hoskins, et al.,Proc. Natl. Acad. Sci. USA, 1987, 84:349-353.
Huang,Biochemistry, 1969, 8:344-352.
Humphries, et al.,Curr. Opin. Biotechnol., 1991, 2(4):539-543.
Lu and Nelsestuen,Biochemistry, 1996, 35:8193-8200.
Lu and Nelsestuen,Biochemistry, 1996, 35:8201-8209.
Matsubara, et al.,Dev. Biol., 1996, 180:499-510.
Mayer, et al.,Biochemistry, 1983, 22(2):316-321.
McDonald, et al.Biochemistry, 1997, 36:5120-5137.
McDonald, et al.,Biochemistry, 1997, 36:(50):15589-15598.
Morrissey, et al.,Blood, 1993, 81(3):734-744.
Muir, et al.,Curr. Opin. Biotechnol., 1993, 4(4):420-427.
Nakagaki, et al.,Biochemistry, 1991, 30:10819-10824.
Nelsestuen and Suttie,Biochem. Biophys. Res. Commun., 1971, 45:198-203.
Nelsestuen, et al.,Biochemistry, 1977, 16(19):4164-4171.
Nicolaes, et al.,Thromb. Haemost., 1996, 76:404-410.
Nicolaisen, et al.,Thromb. Haemost., 1996, 76:200-204.
Perera, et al.,Biochemistry, 1998, 37:10920-10927.
Persson and Nielsen,FEBS Letters, 1996, 385(3):241-243.
Petersen, et al.,Biochemistry, 1990, 29:3451-3457.
Ratcliffe, et al.,J. Biol. Chem., 1993, 268(32):24339-24345.
Resnick and Nelsestuen,Biochemistry, 1980, 19(13):3028-3033.
Rezaie and Esmon,J. Biol. Chem., 1992, 267:26104-26109.
Schmidel, et al.,J. Biol. Chem., 1990, 29(34):7845-7852.
Schwalbe, et al.,J. Biol. Chem., 1989, 264:20288-20296.
Seshadri, et al.,Biochemistry, 1994, 33:1087-1092.
Shah, et al.,Proc. Natl. Acad. Sci. USA, 1998, 95(8):4229-4234.
Shen, et al.,Biochemistry, 1997, 36(51):16025-16031.
Shen, et al.,J. Biol. Chem., 1998, 273(47):31086-31091.
Schulman, et al.,Thromb. Haemost., 1996, 75(3):432-436.
Smirnov, et al.,J. Biol. Chem., 1998, 273(15):9031-9040.
Sorensen, et al.,J. Biol. Chem., 1997, 272(18):11863-11868.
Thariath, et al.,Biochem J., 1997, 322:309-315.
Thomsen, et al.,Thromb. Haemost., 1993, 70(3):458-464.
Vallette, et al.,Nucleic Acids Res., 1989, 17(2):723-733.
Vrana, et al.,Cancer Res., 56:5063-5070.
Weber, et al.,J. Biol. Chem., 1992, 267(7):4564-4569.
Wei, et al.,Biochemistry, 1982, 21:1949-1959.
Welsch, et al.,Biochemistry, 1988, 27:4933-4938.
Welsch and Nelsestuen,Biochemistry, 1988, 27:4939-4945.
Yan, et al.,Bio/Technology, 1990, 8:655-661.
Zhang, et al.,Blood, 1992, 80(4):942-952.
Zhang, et al.,J. Biol. Chem., 1993, 268 (16):12040-12045.
Zwaal, et al.,Biochimica et Biophysica, 1998, 1376:433-453.
Cheung et al., “Localization of an Epitope of a Calcium-Dependent Monoclonal Antibody to the N-Terminal Region of the Gla Domain of Human Factor VII,”Thrombosis Research, 1995, 79(2):199-206.
EMBL Aceession No. AF465270 (Feb. 2, 2003).
Martinez et al., “Underdecarboxlyation of Vitamin K-Dependent Proteins: Occasionally Severe, Possibly Universal,” Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics, May 27-31, 2001, Chicago, Illinois, 2 pgs.
Mayer, “Ultra-early hemostatic therapy for intracerebral hemorrhage,” Stroke 2003, 34:224-229.
Bragdon Kathleen Kerr
Fish & Richardson P.C.
Kim Alexander
Regents of the University of Minnesota
LandOfFree
Modified vitamin K-dependent polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified vitamin K-dependent polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified vitamin K-dependent polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2753472